Cefixime and Rhabdomyolysis - a phase IV clinical study of FDA data

Summary:

Rhabdomyolysis is reported as a side effect among people who take Cefixime (cefixime), especially for people who are female, 30-39 old, also take Vancomycin, and have Dyslipidaemia.

The phase IV clinical study analyzes which people have Rhabdomyolysis when taking Cefixime. It is created by eHealthMe based on reports of 3,217 people who have side effects when taking Cefixime from the FDA, and is updated regularly.

What is Cefixime?

Cefixime has active ingredients of cefixime. eHealthMe is studying from 3,237 Cefixime users. Check the latest studies of Cefixime.

What is Rhabdomyolysis?

Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down) is found to be associated with 1,556 drugs and 1,922 conditions by eHealthMe. Check the latest studies of Rhabdomyolysis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

3,217 people reported to have side effects when taking Cefixime.
Among them, 16 people (0.5%) have Rhabdomyolysis.

Among these 16 people:

What is the gender of people who have Rhabdomyolysis when taking Cefixime? *

female: 75 %
male: 25 %

What is the age of people who have Rhabdomyolysis when taking Cefixime? *

What are other drugs people take besides Cefixime? *

Vancomycin: 5 people, 31.25%
Zopiclone: 4 people, 25.00%
Xyzal: 4 people, 25.00%
Lescol Xl: 4 people, 25.00%
Clonazepam: 2 people, 12.50%
Invega: 2 people, 12.50%
Pramipexole Dihydrochloride: 2 people, 12.50%
Dexlansoprazole: 2 people, 12.50%
Depakote Er: 2 people, 12.50%
Humira: 2 people, 12.50%

What are other side effects people have besides Rhabdomyolysis? *

Nausea (feeling of having an urge to vomit): 6 people, 37.50%
Serotonin Syndrome (occurs when two drugs that affect the body's level of serotonin are taken together at the same time): 5 people, 31.25%
General Physical Health Deterioration (weak health status): 4 people, 25.00%
Fibrin D Dimer Increased: 4 people, 25.00%
Blood Calcium Decreased: 4 people, 25.00%
Insomnia (sleeplessness): 4 people, 25.00%
Hypoaesthesia (reduced sense of touch or sensation): 4 people, 25.00%
Hypersensitivity: 4 people, 25.00%
High Blood Pressure: 4 people, 25.00%
High Blood Cholesterol: 4 people, 25.00%

What are the existing conditions these people have? *

Pulmonary Tuberculosis (lungs tuberculosis): 4 people, 25.00%
Pain: 4 people, 25.00%
Dyslipidaemia (abnormal amount of lipids): 4 people, 25.00%
Vascular Pseudoaneurysm (leakage of arterial blood from an artery into the surrounding tissue with a continuing communication between the originating artery and the resultant adjacent cavity): 3 people, 18.75%
Cardiac Pseudoaneurysm (leaking of a heart artery with blood collection): 3 people, 18.75%
Pneumonia: 3 people, 18.75%
Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 3 people, 18.75%
High Blood Cholesterol: 2 people, 12.50%
Stress And Anxiety: 2 people, 12.50%
Bipolar Disorder (mood disorder): 2 people, 12.50%

* Approximation only. Some reports may have incomplete information.

Do you take Cefixime and have Rhabdomyolysis?

- Check whether Rhabdomyolysis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cefixime:

Cefixime (3,237 reports)

Rhabdomyolysis treatments and more:

Rhabdomyolysis (60,893 reports)

Browse all side effects of Cefixime:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Rhabdomyolysis:

Rhabdomyolysis (1,556 drugs)

Browse all the conditions that are associated with Rhabdomyolysis:

Rhabdomyolysis (1,922 conditions)

Related publications that referenced our studies

Rezigh, A. B., Armenia, E., Li, T., & Soesilo, I. , "Rifaximin as a rare cause of rhabdomyolysis in cirrhosis", Clinical case reports, 2018 Jan .
Moye, P. M., Manasen, S., & O’Brien, K., "Sulfamethoxazole-Trimethoprim-Induced Rhabdomyolysis in an Immunocompetent Patient: A Case Report", Medicine, 2014 Jan .
Rezigh, A. B., Armenia, E., Li, T., & Soesilo, I. , "Rifaximin as a rare cause of rhabdomyolysis in cirrhosis", Clinical case reports, 2018 Jan .
Moye, P. M., Manasen, S., & O’Brien, K., "Sulfamethoxazole-Trimethoprim-Induced Rhabdomyolysis in an Immunocompetent Patient: A Case Report", Medicine, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on cefixime (the active ingredients of Cefixime) and Cefixime (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.